Cambridge Healthtech Institute’s 13th Annual
Display of Biologics
Leading the Way for New Classes of Therapy
17 November 2026
Progress in phage, yeast, and mammalian display is responsible for the creation of a growing arsenal of emerging and increasingly complex biologic constructs, including multispecifics, ADCs, TCEs, and immunotherapies. The integration of ML/AI and modelling techniques into the discovery workflow to assess developability and enable optimisation of candidates is driving efficiency and improvement of candidates. New strategies for conditional activation, including targeted degraders and masking approaches, allow biologics to hit the tumour before they become activated, reducing off-target toxicity and adverse events. Cambridge Healthtech Institute's thirteenth-annual Display of Biologics conference is the cornerstone of the PEGS Europe Summit, and will feature thought leaders advancing new classes of therapy.
Coverage will include, but is not limited to:
- Developing novel platforms for phage, yeast, and mammalian display
- Embedding in silico design and ML/AI into novel workflows
- Enabling computationally designed repertoires of antibodies and biologics
- Identifying novel biologics for autoimmune disease
- Addressing complex targets: Ion channels, GPCRs, BBB
- Applying phage and mammalian display to optimising therapeutic antibodies
- Using structure-guided design of antibody repertoires to select drug-like properties
- Guiding complex format design with ML/AI
- Bridging conventional phage display with ML/AI
- Blending yeast display and NGS screening methods for peptide binder discovery
The deadline for priority consideration is 26 March 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: